Schulte-Sinkus D, Standl T
Abteilung für Anästhesiologie Universitäts-Krankenhaus Eppendorf, Hamburg.
Anasthesiol Intensivmed Notfallmed Schmerzther. 1998 Feb;33(2):124-8. doi: 10.1055/s-2007-994226.
We report on a 30-year old female patient with suspected fulminant pulmonary embolism and cardiac arrest following ambulatory arthroscopy nine days before the event. After 15 minutes of unsuccessful cardiopulmonary resuscitation (CPR) on the ambulance the patient was transferred to the emergency unit of a hospital and was treated with bolus injection of 50 mg t-PA initially and 50 mg over the next two hours. Five minutes after the initial bolus the circulation could be stabilised and the patient could be extubated the next morning. The patient did not present any neurological deficit on the day of discharge nor did she show any bleeding complications. The time elapsing from notice to emergency service to arrival at hospital was about 35 minutes.
In patients with massive and life-threatening pulmonary embolism thrombolysis offers an opportunity to manage this critical situation. Due to the serious prognosis of these patients the potential benefit of thrombolysis outweighs the lack of preceding diagnostic procedures and the risk of potential side-effects.
In the light of an excellent outcome of this patient thrombolytic therapy with t-PA appears to be justified under continued CPR if fulminant pulmonary embolism is suspected.
我们报告了一名30岁女性患者,在事件发生九天前进行门诊关节镜检查后疑似发生暴发性肺栓塞并心脏骤停。在救护车上进行15分钟的心肺复苏(CPR)未成功后,患者被转至一家医院的急诊科,最初静脉推注50毫克组织型纤溶酶原激活剂(t-PA),并在接下来的两小时内再推注50毫克。首次推注后五分钟,循环得以稳定,患者于次日早晨拔管。出院当天患者未出现任何神经功能缺损,也未出现任何出血并发症。从通知急救服务到抵达医院的时间约为35分钟。
对于发生大面积且危及生命的肺栓塞患者,溶栓治疗为处理这一危急情况提供了机会。鉴于这些患者的严重预后,溶栓治疗的潜在益处超过了缺乏前期诊断程序以及潜在副作用的风险。
鉴于该患者的良好预后,如果怀疑发生暴发性肺栓塞,在持续心肺复苏的情况下使用t-PA进行溶栓治疗似乎是合理的。